Scarica l'app Stockscreener
5.17
3.72%
-0.20
Dopo l'orario di chiusura:
5.19
0.02
+0.39%
Precedente Chiudi:
$5.37
Aprire:
$5.36
Volume 24 ore:
1.44M
Relative Volume:
0.73
Capitalizzazione di mercato:
$919.55M
Reddito:
-
Utile/perdita netta:
$-45.44M
Rapporto P/E:
-14.77
EPS:
-0.35
Flusso di cassa netto:
$-42.28M
1 W Prestazione:
+0.00%
1M Prestazione:
-0.96%
6M Prestazione:
+97.33%
1 anno Prestazione:
+269.29%
Intervallo 1D:
$5.045
$5.405
Intervallo di 1 settimana:
$5.045
$5.45
Portata 52W:
$1.33
$5.86
Compass Therapeutics Inc Stock (CMPX) Company Profile
Nome
Compass Therapeutics Inc
Settore
Industria
Telefono
617-500-8099
Indirizzo
80 GUEST STREET, BOSTON
Confronta CMPX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
5.17 | 955.12M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-03 | Iniziato | Canaccord Genuity | Buy |
| 2025-12-03 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-12-03 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-07-01 | Ripresa | Raymond James | Outperform |
| 2025-04-02 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-24 | Iniziato | Guggenheim | Buy |
| 2025-02-19 | Iniziato | Piper Sandler | Overweight |
| 2024-12-23 | Iniziato | D. Boral Capital | Buy |
| 2024-11-15 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-16 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2023-01-31 | Iniziato | Jefferies | Buy |
| 2023-01-27 | Iniziato | Stifel | Buy |
| 2022-05-23 | Ripresa | H.C. Wainwright | Buy |
| 2022-03-15 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-01-19 | Iniziato | B. Riley Securities | Buy |
| 2021-12-22 | Iniziato | Raymond James | Outperform |
| 2021-12-20 | Iniziato | SVB Leerink | Outperform |
| 2021-12-15 | Iniziato | Wedbush | Outperform |
Mostra tutto
Compass Therapeutics Inc Borsa (CMPX) Ultime notizie
Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Shares Up 4.5% – What’s Next? - Defense World
Compass Therapeutics (NASDAQ:CMPX) Shares Up 4.5%What's Next? - MarketBeat
Compass Therapeutics files for up to $400 million mixed shelf offeringSEC filing - marketscreener.com
Compass Therapeutics Files $400 Million Mixed Shelf - marketscreener.com
Compass Therapeutics’ (CMPX) Tovecimig Drives Strong Analyst Sentiment - Insider Monkey
Compass Therapeutics' (CMPX) Tovecimig Drives Strong Analyst Sentiment - Finviz
Published on: 2025-12-21 11:19:43 - moha.gov.vn
Compass Therapeutics Earnings Notes - Trefis
Are Medical Stocks Lagging Compass Therapeutics, Inc. (CMPX) This Year? - Yahoo Finance
Is Compass Therapeutics Inc. stock a defensive play in 2025Weekly Loss Report & Technical Confirmation Alerts - DonanımHaber
How Compass Therapeutics Inc. stock reacts to global recession fearsQuarterly Earnings Summary & Community Verified Swing Trade Signals - DonanımHaber
Why Compass Therapeutics Inc. stock could outperform in 2025July 2025 Technicals & Fast Gain Swing Alerts - DonanımHaber
Patterns Watch: How Compass Therapeutics Inc. stock reacts to global recession fearsPrice Action & Low Risk Profit Maximizing Plans - DonanımHaber
Why analysts remain bullish on Compass Therapeutics Inc. stockJuly 2025 Reactions & Precise Buy Zone Tips - Улправда
How Compass Therapeutics Inc. stock trades during market volatilityWeekly Stock Recap & Comprehensive Market Scan Reports - Улправда
Signal Recap: Is Compass Therapeutics Inc. stock in correction or buying zone2025 Earnings Impact & Low Drawdown Investment Ideas - ulpravda.ru
Published on: 2025-12-19 03:17:09 - Улправда
Published on: 2025-12-19 02:57:37 - Улправда
Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference - Yahoo Finance
Wall Street analysts think Compass Therapeutics, Inc. (CMPX) could surge 134.14%: Read this before placing a bet - MSN
Here's why Compass Therapeutics, Inc. (CMPX) is a great momentum stock to buy - MSN
Wall Street Analysts Think Compass Therapeutics, Inc. (CMPX) Could Surge 134.14%: Read This Before Placing a Bet - Zacks Investment Research
An analyst sees good growth prospects for Compass Therapeutics Inc (CMPX) - Setenews
Vivo Capital LLC Purchases 2,487,443 Shares of Compass Therapeutics, Inc. $CMPX - MarketBeat
Here's Why Compass Therapeutics, Inc. (CMPX) is a Great Momentum Stock to Buy - sharewise.com
Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Compass Therapeutics announces public offering of common stock By Investing.com - Investing.com Nigeria
Compass Therapeutics (NASDAQ:CMPX) Coverage Initiated at Citizens Jmp - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Now Covered by Analysts at Canaccord Genuity Group - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Coverage Initiated by Analysts at Citizens Jmp - Defense World
Analysts Are Bullish on These Healthcare Stocks: Schrodinger (SDGR), Compass Therapeutics (CMPX) - The Globe and Mail
Compass Therapeutics (NASDAQ:CMPX) Coverage Initiated by Analysts at Canaccord Genuity Group - Defense World
Citizens Initiates Coverage of Compass Therapeutics (CMPX) with Market Outperform Recommendation - Nasdaq
Compass Therapeutics (NASDAQ:CMPX) Trading Down 6%Time to Sell? - MarketBeat
CMPX Analyst Rating Update: Citizens Initiates Coverage with Mar - GuruFocus
This Linde Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Cantor Fitzgerald Initiates Compass Therapeutics at Overweight - marketscreener.com
Cantor Fitzgerald initiates Compass Therapeutics stock with Overweight rating By Investing.com - Investing.com UK
Compass Therapeutics stock initiated at Market Outperform by Citizens - Investing.com Canada
The growth track for Compass Therapeutics Inc (CMPX) has changed recently - Setenews
Compass Therapeutics (NASDAQ:CMPX) Sets New 52-Week HighTime to Buy? - MarketBeat
Compass Therapeutics (CMPX) Up 9.0% After Advancing Oncology Pipeline Updates at Key Healthcare Conference - Sahm
Strong Analyst Confidence in Compass Therapeutics (CMPX) Driven by CTX-10726 Advancement - Insider Monkey
Compass Therapeutics stock hits 52-week high at 5.86 USD By Investing.com - Investing.com Nigeria
Compass Therapeutics stock hits 52-week high at 5.86 USD - Investing.com
Compass Therapeutics (CMPX) Is Up 17.2% After Analyst Highlights Pipeline Progress and Anticipated Tovecimig Data – Has the Bull Case Changed? - Yahoo Finance
Analysts Issue Forecasts for CMPX FY2025 Earnings - Defense World
A Look at Compass Therapeutics (CMPX) Valuation Following Strong CTX-10726 Preclinical Data and Management Update - Yahoo Finance
Compass Therapeutics (CMPX): Evaluating Valuation After a 55% 1-Month Share Price Surge - Sahm
Compass Therapeutics Inc Azioni (CMPX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):